CI Investments Inc’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-147,170
Closed -$1.16M 1330
2022
Q4
$1.16M Buy
147,170
+700
+0.5% +$4.92K 0.01% 356
2022
Q3
$901K Sell
146,470
-197,680
-57% -$1.19M ﹤0.01% 386
2022
Q2
$1.82M Buy
344,150
+185,100
+116% +$1.12M 0.01% 345
2022
Q1
$1.04M Buy
159,050
+78,242
+97% +$697K ﹤0.01% 426
2021
Q4
$1.32M Buy
80,808
+45,100
+126% +$940K ﹤0.01% 419
2021
Q3
$1.04M Sell
35,708
-14,081
-28% -$468K ﹤0.01% 454
2021
Q2
$1.73M Sell
49,789
-12,700
-20% -$403K 0.01% 414
2021
Q1
$1.97M Buy
62,489
+35,289
+130% +$1.43M 0.01% 344
2020
Q4
$1.28M Buy
27,200
+1,800
+7% +$83.6K 0.01% 360
2020
Q3
$1.18M Buy
25,400
+21,000
+477% +$721K 0.01% 345
2020
Q2
$159K Buy
4,400
+100
+2% +$3.68K ﹤0.01% 541
2020
Q1
$153K Buy
+4,300
New +$176K ﹤0.01% 506

Other funds holding ZYME

CI Investments Inc's ZYME Position: Q1 2023 in Review

CI Investments Inc sold out of Zymeworks (ZYME) in Q1 2023, closing a stake of 147,170 shares — an estimated $1.16M sold.

CI Investments Inc first reported a position in ZYME in Q1 2020 and held it in 12 quarters. The position peaked at $1.97M in Q1 2021. 115 funds tracked by Wall St. Rank hold ZYME as of Q1 2023.

  • CI Investments Inc reported no remaining Zymeworks position as of Q1 2023 after selling out during the quarter.
  • CI Investments Inc sold 147,170 Zymeworks shares in Q1 2023, an estimated $1.16M.
  • CI Investments Inc first reported a position in Zymeworks in Q1 2020 and held it in 12 quarters.
  • CI Investments Inc's Zymeworks position peaked at $1.97M in Q1 2021.
  • 115 funds tracked by Wall St. Rank held Zymeworks as of Q1 2023.

Based on CI Investments Inc's 13F filing for Q1 2023, filed 12 May 2023.